J. Safra Sarasin Holding’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-6,153
Closed -$2.36M 510
2025
Q2
$2.36M Sell
6,153
-5,380
-47% -$1.94M 0.04% 196
2025
Q1
$3.99M Buy
11,533
+220
+2% +$70.8K 0.07% 147
2024
Q4
$3.4M Sell
11,313
-918
-8% -$321K 0.06% 162
2024
Q3
$4.97M Sell
12,231
-383
-3% -$140K 0.09% 135
2024
Q2
$4.05M Buy
+12,614
New +$4.1M 0.07% 147

Other funds holding HCA

J. Safra Sarasin Holding's HCA Position: Q3 2025 in Review

J. Safra Sarasin Holding sold out of HCA Healthcare (HCA) in Q3 2025, closing a stake of 6,153 shares — an estimated $2.36M sold.

J. Safra Sarasin Holding first reported a position in HCA in Q2 2024 and held it in 5 quarters. The position peaked at $4.97M in Q3 2024. 1,286 funds tracked by Wall St. Rank hold HCA as of Q3 2025.

  • J. Safra Sarasin Holding reported no remaining HCA Healthcare position as of Q3 2025 after selling out during the quarter.
  • J. Safra Sarasin Holding sold 6,153 HCA Healthcare shares in Q3 2025, an estimated $2.36M.
  • J. Safra Sarasin Holding first reported a position in HCA Healthcare in Q2 2024 and held it in 5 quarters.
  • J. Safra Sarasin Holding's HCA Healthcare position peaked at $4.97M in Q3 2024.
  • 1,286 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2025.

Based on J. Safra Sarasin Holding's 13F filing for Q3 2025, filed 3 Nov 2025.